NCT00445510View on ClinicalTrials.gov

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Conditions
Asthma
Interventions
DRUG

GSK256066

Trial Locations (1)

6035

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY